Info
Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, discusses the issue of patients or payers objecting to repeat biopsies.
10 years ago
#alk, #biopsy, #cancer, #cancergrace, #dana, #egfr, #geoffrey, #grace, #gracecast, #histology, #institute, #marker, #molecular, #mutation, #nsclc, #oncology, #oxnard, #rearrangement, #repeat, #testing
Discover more
Search
